Mayne Pharma Signs Transaction Agreement & Related License Agreement With TherapeuticsMD
Mayne Pharma Group Ltd MYX:
SIGNED TRANSACTION AGREEMENT AND RELATED LICENSE AGREEMENT WITH THERAPEUTICSMD
COMPLETION IS EXPECTED BY END OF CALENDAR YEAR 2022 PENDING SATISFACTION OF CUSTOMARY CLOSING CONDITIONS
DEAL FOR US$140 MILLION
DEAL IMMEDIATELY ADDITIVE TO NET PROFIT AFTER TAX